Digital health news briefs for 2/15/2018

Insulin dose tool gains CE Mark.  DreaMed Diabetes has received a CE Mark for its Type 1-focused clinical decision support (CDS) platform, Advisor Pro. The tool’s algorithms process data from a number of connected diabetes management devices to provide a personalized insulin dosing treatment plan.
Source: mobihealthnews - Category: Information Technology Source Type: news